EATONTOWN, N.J., Jan. 15, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading biotech company in the regenerative medicine industry, announced today it will participate at the American Academy of Cosmetic Surgery (AACS) annual conference January 16-19, 2013 in Las Vegas (booth #339) to showcase the newly launched ATGRAFT™, adipose tissue storage service.
American CryoStem Medical Advisory Board Member, Mel Bircoll MD, who pioneered liposuction and was the first to incorporate fat transfer into his practice in the 1980's will be presenting to the AACS members, Wednesday, January 16, 2013. In his Continuing Medical Education (CME) presentation, "My 33 Year Experience with Fat Transfer – with a Look to the Future" he will discuss the latest technologies and trends for adipose tissue (fat) storage and transfers. Additionally, during the general session, Saturday, January 19, 2013, Dr. Bircoll's topic of discussion will be, "Innovations for Fat Transfer – Past, Present and Future."
The AACS 29th Annual Scientific Meeting is a multi-specialty, international meeting for cosmetic surgeons and health care professionals. John S. Arnone, CEO commented, "We are participating this year at the conference to unveil our ATGRAFT™ tissue storage service and to speak directly with physicians who use our services." Mr. Arnone further commented, "ATGRAFT™ is a clinical solution for physicians to provide their patients the highest quality fat transfer procedures and technologies. Using the patient's stored tissue allows for bio-compatible layered augmentation and corrective procedures, eliminates multiple liposuctions, provides maximum flexibility, and produces natural lasting results."
Physicians that would like to offer ATGRAFT™ tissue storage services to their patients should visit us at booth #339 at the AACS conference, call 732-747-1007 or email info@americancryostem.com for an information kit.
About American CryoStem: American CryoStem Corporation (OTCQB:CRYO) is a leading biotech company focused on marketing its clinical processing services and patented products for adipose (fat) tissue and adipose derived adult stem cells. Our clinical tissue processing, patented cell culture media products and tissue storage platform supports cosmetic and regenerative medicine applications being developed globally. The Company provides high quality, clinically processed viable cells, while at the same time developing cutting edge applications, therapies, patented laboratory products and services for consumer and commercial applications.